Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 29 matching records.
29 results — page 1 of 2
- Level BRandomized Controlled TrialPubMed
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.
Randomized Controlled Trial with a reported sample of 24 on Neuroinflammation, published in Parkinsons Dis (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
Parkinsons Dis - Level BClinical TrialPubMed
A prospective single-arm study on the effects of repeated intravenous infusions of canine adipose-derived mesenchymal stromal cells in dogs with chronic inflammatory enteropathy.
Clinical Trial on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level CProspective StudyPubMed
Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot Study.
Prospective Study on Systemic / IV, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus3 citations - Level BClinical TrialPubMed
Allogenic Adipose-Derived Mesenchymal Stem Cell Infusion for the Management of Acute-Onset Pancreatitis in Dogs: A Pilot Study.
Clinical Trial with a reported sample of 4 on Chronic Inflammation, published in Animals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
- n = 4
Animals (Basel) - Level DAnimal StudyPubMed
Intravenous Infusion of Exosomes Derived from Human Adipose Tissue-Derived Stem Cells Promotes Angiogenesis and Muscle Regeneration: An Observational Study in a Murine Acute Limb Ischemia Model.
Animal Study with a reported sample of 3 on Hip, Systemic / IV, published in Adv Exp Med Biol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 3
Adv Exp Med Biol2 citations - Level BRandomized Controlled TrialPubMed
Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial.
Randomized Controlled Trial with a reported sample of 48 on Systemic / IV, published in Front Med (Lausanne) (2023) — summary generated from the PubMed abstract.
- 2023
- n = 48
Front Med (Lausanne)4 citations - Level CCase Report / SeriesPubMed
Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report.
Case Report / Series on Spinal Cord Injury, published in Front Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Front Transplant - Level DAnimal StudyPubMed
Graft infusion of adipose-derived mesenchymal stromal cells to prevent rejection in experimental intestinal transplantation: A feasibility study.
Animal Study on Chronic Inflammation, Immune Modulation, published in Clin Transplant (2021) — summary generated from the PubMed abstract.
- 2021
Clin Transplant2 citations - Level CProspective StudyPubMed
Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson's disease.
Prospective Study on Neuroinflammation, published in Acta Neurol Scand (2021) — summary generated from the PubMed abstract.
- 2021
Acta Neurol Scand12 citations - Level CProspective StudyPubMed
Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy.
Prospective Study on Autoimmune Research, published in Stem Cells Int (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Int18 citations - Level BClinical TrialPubMed
Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical
Clinical Trial, published in JMIR Res Protoc (2020) — summary generated from the PubMed abstract.
- 2020
JMIR Res Protoc - Level BClinical TrialPubMed
Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
Clinical Trial on Type 1 Diabetes, published in Adv Exp Med Biol (2018) — summary generated from the PubMed abstract.
- 2018
Adv Exp Med Biol17 citations - Level DAnimal StudyPubMed
Infusion of adipose‑derived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats.
Animal Study on Type 2 Diabetes, published in Mol Med Rep (2018) — summary generated from the PubMed abstract.
- 2018
Mol Med Rep21 citations - Level DAnimal StudyPubMed
Tail Vein Infusion of Adipose-Derived Mesenchymal Stem Cell Alleviated Inflammatory Response and Improved Blood Brain Barrier Condition by Suppressing Endoplasmic Reticulum Stress in a Middle Cerebral Artery Occlusion Ra
Animal Study on Chronic Inflammation, published in Med Sci Monit (2018) — summary generated from the PubMed abstract.
- 2018
Med Sci Monit32 citations - Level BClinical TrialPubMed
Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety.
Clinical Trial on Chronic Kidney Disease, published in Cell J (2018) — summary generated from the PubMed abstract.
- 2018
Cell J22 citations - Level DAnimal StudyPubMed
Intravenous infusion of adipose-derived stem/stromal cells improves functional recovery of rats with spinal cord injury.
Animal Study on Spinal Cord Injury, published in Cytotherapy (2017) — summary generated from the PubMed abstract.
- 2017
Cytotherapy - Level BClinical TrialPubMed
Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell.
Clinical Trial on Immune Modulation, published in Regen Ther (2017) — summary generated from the PubMed abstract.
- 2017
Regen Ther - Level CProspective StudyPubMed
Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach.
Prospective Study on Spinal Cord Injury, published in Adv Biomed Res (2016) — summary generated from the PubMed abstract.
- 2016
Adv Biomed Res - Level DAnimal StudyPubMed
Microcirculatory Response In Vivo on Local Intraarterial Infusion of Autogenic Adipose-derived Stem Cells or Stromal Vascular Fraction.
Animal Study with a reported sample of 12 on Systemic / IV, published in Plast Reconstr Surg Glob Open (2016) — summary generated from the PubMed abstract.
- 2016
- n = 12
Plast Reconstr Surg Glob Open3 citations - Level DAnimal StudyPubMed
Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor.
Animal Study, published in J Gastroenterol Hepatol (2015) — summary generated from the PubMed abstract.
- 2015
J Gastroenterol Hepatol - Level DAnimal StudyPubMed
Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats.
Animal Study on Systemic / IV, published in Endocr J (2015) — summary generated from the PubMed abstract.
- 2015
Endocr J37 citations - Level CProspective StudyPubMed
Splenectomy enhances the therapeutic effect of adipose tissue-derived mesenchymal stem cell infusion on cirrhosis rats.
Prospective Study, published in Liver Int (2015) — summary generated from the PubMed abstract.
- 2015
Liver Int - Level CCase Report / SeriesPubMed
Co-infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and bone marrow derived hematopoietic stem cells, a viable therapy for post-traumatic brachial plexus injury: a case report.
Case Report / Series on Back & Spine, published in Biomed J (2014) — summary generated from the PubMed abstract.
- 2014
Biomed J - Level CProspective StudyPubMed
Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
Prospective Study with a reported sample of 95 on Systemic / IV, published in Ren Fail (2014) — summary generated from the PubMed abstract.
- 2014
- n = 95
Ren Fail22 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406